Works matching DE "LINAGLIPTIN"
Results: 124
利拉鲁肽联合利格列汀治疗2 型糖尿病肥胖患者的临床研究.
- Published in:
- Progress in Modern Biomedicine, 2019, v. 19, n. 15, p. 2895, doi. 10.13241/j.cnki.pmb.2019.15.021
- By:
- Publication type:
- Article
Linagliptin and secoisolariciresinol diglucoside attenuate hyperlipidemia and cardiac hypertrophy induced by a high-methionine diet in rats via suppression of hyperhomocysteinemia-induced endoplasmic reticulum stress.
- Published in:
- Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1275730
- By:
- Publication type:
- Article
Linagliptin in Combination With Metformin Ameliorates Diabetic Osteoporosis Through Modulating BMP-2 and Sclerostin in the High-Fat Diet Fed C57BL/6 Mice.
- Published in:
- Frontiers in Endocrinology, 2022, v. 13, p. 1, doi. 10.3389/fendo.2022.944323
- By:
- Publication type:
- Article
A Randomized Clinical Trial of Linagliptin vs. Standard of Care in Patients Hospitalized With Diabetes and COVID-19.
- Published in:
- Frontiers in Endocrinology, 2021, v. 12, p. 1, doi. 10.3389/fendo.2021.794382
- By:
- Publication type:
- Article
Summary of Research: Efficacy and Safety of the SGLT2 Inhibitor Empagliflozin Versus Placebo and the DPP-4 Inhibitor Linagliptin Versus Placebo in Young People with Type 2 Diabetes (DINAMO): A Multicentre, Randomised, Double-Blind, Parallel Group, Phase 3 Trial
- Published in:
- Diabetes Therapy, 2024, v. 15, n. 5, p. 893, doi. 10.1007/s13300-024-01555-0
- By:
- Publication type:
- Article
A Randomized, Double-Blind, Parallel-Group Phase III Trial Investigating the Glycemic Efficacy and Safety Profile of Fixed-Dose Combination Dapagliflozin and Linagliptin Over Linagliptin Monotherapy in Patients with Inadequately Controlled Type 2 Diabetes with Metformin
- Published in:
- Diabetes Therapy, 2024, v. 15, n. 1, p. 215, doi. 10.1007/s13300-023-01504-3
- By:
- Publication type:
- Article
Cost-Effectiveness Analysis of Linagliptin in Japan Based on Results from the Asian Subpopulation in the CARMELINA® Trial.
- Published in:
- Diabetes Therapy, 2020, v. 11, n. 8, p. 1721, doi. 10.1007/s13300-020-00852-8
- By:
- Publication type:
- Article
Real-World Glycemic Lowering Effectiveness of Linagliptin Among Adults with Type 2 Diabetes by Age, Renal Function, and Race.
- Published in:
- Diabetes Therapy, 2020, v. 11, n. 7, p. 1527, doi. 10.1007/s13300-020-00841-x
- By:
- Publication type:
- Article
Early Combination Therapy with Linagliptin and Metformin in People with Type 2 Diabetes Improves Glycemic Control to HbA1c ≤ 6.5% without Increasing Hypoglycemia: Pooled Analysis of Two Randomized Clinical Trials.
- Published in:
- Diabetes Therapy, 2020, v. 11, n. 6, p. 1317, doi. 10.1007/s13300-020-00819-9
- By:
- Publication type:
- Article
Long-Term Safety and Effectiveness of Linagliptin in Japanese Patients with Type 2 Diabetes and Renal Dysfunction: a Post-Marketing Surveillance Study.
- Published in:
- Diabetes Therapy, 2020, v. 11, n. 2, p. 523, doi. 10.1007/s13300-019-00754-4
- By:
- Publication type:
- Article
Long-Term Safety and Effectiveness of Linagliptin in Japanese Patients with Type 2 Diabetes Mellitus: A 3-Year Post-Marketing Surveillance Study.
- Published in:
- Diabetes Therapy, 2020, v. 11, n. 1, p. 107, doi. 10.1007/s13300-019-00723-x
- By:
- Publication type:
- Article
The Effect of Linagliptin versus Metformin Treatment-Related Quality of Life in Patients with Type 2 Diabetes Mellitus.
- Published in:
- Diabetes Therapy, 2019, v. 10, n. 1, p. 119, doi. 10.1007/s13300-018-0539-5
- By:
- Publication type:
- Article
Validated Stability Indicating and Assay Method Development of Linagliptin in Formulation by RP-HPLC Using Quality by Design.
- Published in:
- Orbital: The Electronic Journal of Chemistry, 2020, v. 12, n. 2, p. 48, doi. 10.17807/orbital.v12i2.1194
- By:
- Publication type:
- Article
Innovative UV Protocols Based on Straightforward Mathematical Filtration for Concurrent Estimation of Two Antidiabetic Drugs in Their Brand-New Combination: A Comparative Study.
- Published in:
- Journal of AOAC International, 2024, v. 107, n. 1, p. 40, doi. 10.1093/jaoacint/qsad123
- By:
- Publication type:
- Article
Hepatoprotective effect of linagliptin against liver fibrosis induced by carbon tetrachloride in mice.
- Published in:
- Canadian Journal of Physiology & Pharmacology, 2021, v. 99, n. 3, p. 294, doi. 10.1139/cjpp-2020-0049
- By:
- Publication type:
- Article
RELATIVE IN-VITRO DISSOLUTION ANALYSIS USING UV SPECTROSCOPY OF A FEW LINAGLIPTIN GENERIC TABLETS UNDER BIOWAIVER CONDITIONS.
- Published in:
- Biochemical & Cellular Archives, 2024, p. 4219, doi. 10.51470/bca.2024.24.1-S.4215
- By:
- Publication type:
- Article
Validated Method Development For The Simultaneous Estimation Of Empagliflozin, Linagliptin, And Metformin In Marketed Formulation Using Uv Vis Spectrophotometer.
- Published in:
- International Journal of Pharmaceutical Research (09752366), 2020, v. 12, n. 4, p. 5300, doi. 10.31838/ijpr/2020.12.04.702
- By:
- Publication type:
- Article
An overview of recent development towards the synthesis of Linagliptin a DPP-4 inhibitor.
- Published in:
- Chemistry & Biology Interface, 2020, v. 10, n. 5, p. 111
- By:
- Publication type:
- Article
Efficacy and safety of a fixed‐dose combination of dapagliflozin and linagliptin (AJU‐A51) in patients with type 2 diabetes mellitus: A multicentre, randomized, double‐blind, parallel‐group, placebo‐controlled phase III study
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 1, p. 81, doi. 10.1111/dom.15985
- By:
- Publication type:
- Article
Cofrogliptin once every 2 weeks as add‐on therapy to metformin versus daily linagliptin in patients with type 2 diabetes in China: A randomized, double‐blind, non‐inferiority trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 11, p. 5013, doi. 10.1111/dom.15915
- By:
- Publication type:
- Article
Effects of baricitinib, empagliflozin, linagliptin and telmisartan on cardiovascular autonomic neuropathy in type 1 diabetes: An exploratory, randomized, open‐label, crossover trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 10, p. 3064, doi. 10.1111/dom.15180
- By:
- Publication type:
- Article
Incident and recurrent hypoglycaemia with linagliptin and glimepiride over a median of 6 years in the CAROLINA cardiovascular outcome trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 6, p. 1453, doi. 10.1111/dom.14991
- By:
- Publication type:
- Article
Acute effects of linagliptin on intact and total glucagon‐like peptide‐1 and gastric inhibitory polypeptide levels in insulin‐dependent type 2 diabetes patients with and without moderate renal impairment.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 5, p. 806, doi. 10.1111/dom.14636
- By:
- Publication type:
- Article
Postprandial renal haemodynamic effects of the dipeptidyl peptidase‐4 inhibitor linagliptin versus the sulphonylurea glimepiride in adults with type 2 diabetes (RENALIS): A predefined substudy of a randomized, double‐blind trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 1, p. 115, doi. 10.1111/dom.14557
- By:
- Publication type:
- Article
Urinary dipeptidyl peptidase‐4 protein is increased by linagliptin and is a potential predictive marker of urine albumin‐to‐creatinine ratio reduction in patients with type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 8, p. 1968, doi. 10.1111/dom.14407
- By:
- Publication type:
- Article
Safety and effectiveness of linagliptin in Korean patients with type 2 diabetes: A postmarketing surveillance study.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 5, p. 1208, doi. 10.1111/dom.14317
- By:
- Publication type:
- Article
Metformin dose increase versus added linagliptin in non‐alcoholic fatty liver disease and type 2 diabetes: An analysis of the J‐LINK study.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 3, p. 832, doi. 10.1111/dom.14263
- By:
- Publication type:
- Article
Cardiovascular outcomes and safety with linagliptin, a dipeptidyl peptidase‐4 inhibitor, compared with the sulphonylurea glimepiride in older people with type 2 diabetes: A subgroup analysis of the randomized CAROLINA trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 2, p. 569, doi. 10.1111/dom.14254
- By:
- Publication type:
- Article
Efficacy and safety of linagliptin as add‐on therapy to insulin in Chinese patients with type 2 diabetes mellitus: A randomized, double‐blind, placebo‐controlled trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 2, p. 642, doi. 10.1111/dom.14231
- By:
- Publication type:
- Article
IMPURITY PROFILING STABILITY INDICATING METHOD DEVELOPMENT AND VALIDATION OF LINAGLIPTIN AND LC-MS CHARACTERIZATION OF OXIDATIVE DEGRADATION PRODUCT.
- Published in:
- Rasayan Journal of Chemistry, 2023, v. 16, n. 4, p. 2386, doi. 10.31788/RJC.2023.1648536
- By:
- Publication type:
- Article
QUANTIFICATION OF HAZARDOUS HIGH BOILING SOLVENTS IMPURITIES IN ANTI-DIABETIC DRUG LINAGLIPTIN BY NOVEL GC-ALS METHOD DEVELOPMENT AND VALIDATION.
- Published in:
- Rasayan Journal of Chemistry, 2023, v. 16, n. 3, p. 1089, doi. 10.31788/RJC.2023.1638331
- By:
- Publication type:
- Article
Efficacy and Safety of Linagliptin and Insulin in Patients of Type 2 Diabetes Mellitus with Grade 3-5 Chronic Kidney Disease in a Tertiary Care Hospital.
- Published in:
- Journal of Clinical & Diagnostic Research, 2021, v. 15, n. 8, p. 12, doi. 10.7860/JCDR/2021/50693.15204
- By:
- Publication type:
- Article
The Renoprotective Effect of Linagliptin in Type 2 Diabetic Patients with Severely Increased Albuminuria.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Analysis of the Clinical Characteristics of Dipeptidyl Peptidase-4 Inhibitor–Induced Bullous Pemphigoid.
- Published in:
- Annals of Pharmacotherapy, 2022, v. 56, n. 2, p. 205, doi. 10.1177/10600280211022722
- By:
- Publication type:
- Article
Mechanism of Linagliptin on Stromal Cell-Derived Factor 1 and Vascular Endothelial Growth Factor Protein after Molar Pulp Revascularization in Rats.
- Published in:
- Indian Journal of Pharmaceutical Sciences, 2024, v. 86, n. 2, p. 634, doi. 10.36468/pharmaceutical-sciences.1317
- By:
- Publication type:
- Article
Comparative Safety of Dipeptidyl Peptidase‐4 Inhibitors and Sudden Cardiac Arrest and Ventricular Arrhythmia: Population‐Based Cohort Studies.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 111, n. 1, p. 227, doi. 10.1002/cpt.2381
- By:
- Publication type:
- Article
Green and white MEKC for determination of different anti-diabetic binary mixtures and their triple-combo pill.
- Published in:
- BMC Chemistry, 2023, v. 17, n. 1, p. 1, doi. 10.1186/s13065-023-00997-0
- By:
- Publication type:
- Article
Synergistic Antitumor and Apoptotic Activity of Sitagliptin or Linagliptin Plus Cisplatin Against A549 Lung Cancer Cells (An Invitro Study).
- Published in:
- Journal of Contemporary Medical Sciences, 2024, v. 10, n. 3, p. 228, doi. 10.22317/jcms.v10i3.1555
- By:
- Publication type:
- Article
Sensitive Simultaneous Measurement of Metformin and Linagliptin in Plasma Samples by Couple of Nano Graphene Oxide-based Dispersive Solid Phase Extraction Method and Liquid Chromatography.
- Published in:
- Iranian Journal of Pharmaceutical Research, 2020, v. 19, n. 2, p. 274, doi. 10.22037/ijpr.2019.111659.13292
- By:
- Publication type:
- Article
Simultaneous estimation of dapagliflozin and linagliptin using reverse phase-HPLC with photo diode array (PDA).
- Published in:
- Journal of Chemical Metrology, 2024, v. 18, n. 1, p. 19, doi. 10.25135/jcm.104.2401.3020
- By:
- Publication type:
- Article
Characterization of Linagliptin–Ferulic Acid Cocrystal with Improved Thermal and Photostability.
- Published in:
- Bulletin of the Korean Chemical Society, 2019, v. 40, n. 5, p. 453, doi. 10.1002/bkcs.11702
- By:
- Publication type:
- Article
DPP‐4 inhibitor linagliptin ameliorates imiquimod‐induced psoriasis‐like skin alterations in type 2 diabetic mice by inhibiting the MAPK/NF‐κB inflammatory pathway.
- Published in:
- Drug Development Research, 2022, v. 83, n. 6, p. 1373, doi. 10.1002/ddr.21966
- By:
- Publication type:
- Article
Linagliptin in combination with insulin suppresses apoptotic unfolded protein response in ovaries exposed to type 1 diabetes.
- Published in:
- Cell Biochemistry & Function, 2024, v. 42, n. 2, p. 1, doi. 10.1002/cbf.3898
- By:
- Publication type:
- Article
Association of Glucose-Lowering Drugs With Outcomes in Patients With Diabetes Before Hospitalization for COVID-19: A Systematic Review and Network Meta-analysis.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 12, p. e2244652, doi. 10.1001/jamanetworkopen.2022.44652
- By:
- Publication type:
- Article
高效液相色谱一串联质谱法快速测定保健食品中 4种降血糖类药物.
- Published in:
- Food & Machinery, 2022, n. 2, p. 46, doi. 10.13652/j.issn.1003-5788.2022.02.008
- By:
- Publication type:
- Article
The combination of linagliptin and metformin rescues bone loss in type 2 diabetic osteoporosis.
- Published in:
- Journal of Drug Targeting, 2023, v. 31, n. 6, p. 646, doi. 10.1080/1061186X.2023.2216894
- By:
- Publication type:
- Article
Effects of linagliptin on inflammatory factors and arteriosclerosis in patients with newly diagnosed type 2 diabetes mellitus.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2021, v. 30, n. 8, p. 692, doi. 10.5246/jcps.2021.08.057
- By:
- Publication type:
- Article
Cardioprotective effect of Linagliptin on diabetic Wistar rats.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2021, v. 30, n. 4, p. 334, doi. 10.5246/jcps.2021.04.027
- By:
- Publication type:
- Article
Spectrophotometric estimation of linagliptin using ion-pair complexation and oxidative coupling reactions - A green approach.
- Published in:
- Thai Journal of Pharmaceutical Sciences, 2020, v. 44, n. 4, p. 245
- By:
- Publication type:
- Article
Liraglutide and Robust A1C Reductions Among People With Type 2 Diabetes Requiring Appetite Control: A Review of Two Cases.
- Published in:
- Diabetes Spectrum, 2024, v. 37, n. 2, p. 175, doi. 10.2337/ds23-0052
- By:
- Publication type:
- Article